Renal Business Today - dialysis, end-stage renal disease (ESRD), home dialysis, chronic kidney disease (CKD), nephrology, Medicare bundle, kidney, dialysis practice management, kidney disease patients

FEATURES

U.S. Renal Care Settles Fraud Case

BALTIMORE—U.S. Renal Care has agreed to pay $7.3 million to the federal government to settle a whistleblower lawsuit brought by a nurse that alleged a company U.S. Renal Care acquired, Dialysis Corporation of America (DCA), ...read more

Travel on Dialysis

“The world is a book, and those who do not travel read only one page,” said Augustine of Hippo. For many, travel provides an expanded world view and a great deal of joy. For many hemodialysis patients, travel seems ...read more

2013 RPA Meeting

If you missed the three-day, 2013 Renal Physician Association conference held in New Orleans, Renal Business Today was there and has the highlights available at your fingertips in the latest digital issue. Renal ...read more

Venous Needle Dislodgement

Venous needle dislodgement (VND) occurs when a venous needle dislodges from a patient's vascular access during hemodialysis treatment. This report discusses VND severity and presents best practices and other solutions to ...read more

A Recipe Guide to Lowering Salt Intake

Whether you are a kidney disease patient or a non-kidney patient, it is important to keep your kidneys as healthy as possible by following a low-sodium diet. Did you know that for a healthy individual over the age of 50, a ...read more

Latest Headlines

NKF, Abbott partner in nutrition program

NEW YORK--The National Kidney Foundation and Abbott's Ross Products Division have teamed up to develop education programs that will focus on nutrition in chronic kidney disease patients. ...More
October 30, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
Shire releases 500 mg Fosrenol tablet

PHILADELPHIA--British drugmaker Shire Pharmaceuticals has added a 500 mg tablet of Fosrenol to its "reformulated portfolio" that will give patients more flexibility with more dosing options, the company said today. ...More
October 30, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
American Renal opens 8 clinics in 2006, moves corporate offices

BEVERLY, Mass.--American Renal Associates Inc. has opened eight dialysis facilities so far in 2006 and has moved its corporate offices in order to handle the company's growing staff, the company said today. ...More
October 26, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
Rockwell's Dri-Sate mix gets Canadian patent

WIXOM, Mich.--Rockwell Medical Technologies Inc. has received a Canadian patent for its Dri-Sate Dry Acid Concentrate Mix System, according to a company news release. ...More
October 25, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
TA Associates completes $130 million deal with American Access Care

BOSTON--TA Associates, a private equity firm, has completed a $130 million minority leveraged recapitalization of American Access Care, which operates freestanding outpatient vascular access centers. ...More
October 25, 2006
Posted in News, Business, Clinical & Pharma
Roche, Amgen EPO trial set for September 2007

The date has been set, and Amgen and Roche are preparing for legal battle. In a Boston federal district court yesterday, Judge William Young said Amgen and Roche will begin their patent infringement trial in September 2007. Amgen alleges that Roche's anemia treatment ...More
October 24, 2006
Posted in Blog
RenaMed suspends clinial trials for renal assist device

WESTBOROUGH, Mass.--RenaMed Biologics Inc. has suspended clinical trials for its renal assist device (RAD) cartridge, according to a news report. ...More
October 23, 2006
Posted in News, Clinical & Pharma
Fresenius, Amgen agree to 5-year EPO deal

LEXINGTON, Mass--Fresenius Medical Care and Amgen have agreed to a deal that makes Amgen the sole supplier of Epogen and Aranesp to Fresenius for five years. ...More
October 23, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
Amgen to move forward in patent case against Roche

BOSTON--Amgen will be able to move forward with its lawsuit that alleges Roche's anemia drug Mircera infringes on existing U.S. patents, after a federal judge on Friday threw out Roche's motion to dismiss the trial. ...More
October 23, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation
Could Medicare for All really work?

Universal health care sure has a nice ring to it. And it seems to be an easy solution to aiding the rapidly rising numbers of uninsured Americans that hit a record 46.6 million in 2004. But I wonder if it is really feasible, especially when one looks at how Medicare has ...More
October 12, 2006
Posted in Blog